Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam
Although the incidence of tuberculosis was lower in the levofloxacin group than in the placebo group at 30 months, the difference was not significant. (Funded by the National Health and Medical Research Council of Australia; VQUIN MDR Australia New Zealand Clinical Trials Registry number, ACTRN12616000215426.).
Authors
- Frances Garden (ORCID: https://orcid.org/0000-0003-1653-3031)
- Emily MacLean (ORCID: https://orcid.org/0000-0001-9272-0985)
- Pham Ngoc Yen
- Nguyễn Hữu Lân
- Ben J. Marais (ORCID: https://orcid.org/0000-0003-3404-2690)
- Ori Solomon
- Guy B. Marks (ORCID: https://orcid.org/0000-0002-8976-8053)
- Hoa Binh Nguyen (ORCID: https://orcid.org/0000-0002-1543-4907)
- H. Manisha Yapa (ORCID: https://orcid.org/0000-0002-0100-4754)
- Thu Anh Nguyen (ORCID: https://orcid.org/0000-0002-2089-2902)
- Greg J. Fox (ORCID: https://orcid.org/0000-0002-4085-1411)
- David W. Dowdy (ORCID: https://orcid.org/0000-0003-0481-7475)
- Susan A. Graham (ORCID: https://orcid.org/0000-0001-7667-1650)
- Elyse Guevara-Rattray (ORCID: https://orcid.org/0000-0002-7445-2873)
- Marcel A. Behr (ORCID: https://orcid.org/0000-0003-0402-4467)
- Andrea Benedetti (ORCID: https://orcid.org/0000-0002-8314-9497)
- Đức Cường Phạm (ORCID: https://orcid.org/0000-0003-0336-3256)
- Nguyen Viet Nhung (ORCID: https://orcid.org/0000-0002-5447-133X)
- Nguyễn Kim Cương
- Nguyen Cam Binh
Institutions
- Johns Hopkins University (US)
- Sydney Local Health District (AU)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1056/nejmoa2314325
- Citations
- 51
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 19.84
Funders
- National Health and Medical Research Council